News

The MCA21 V3 portal will be unavailable for five days from July 9 to 13, 2025, due to system upgrades and implementation of new forms.

MCA21 V3 Portal Down! Urgent System Upgrade Causes Temporary Shutdown

IL&FS Investment Managers Limited updates NSE and BSE on delay in submitting consolidated financial results for FY 2024-25.

IL&FS penalized for Delay in Submission of Consolidated Financial Results for FY 2024-25

IL&FS Investment penalized for Delay in Submission of Consolidated Financial Results for FY 2024-25

Notifications

The latest amendment by MCA replaces Form CRL-1 under the Companies Act, 2013, easing company-to-LLP conversions and revising the layer restrictions.

MCA amends Form CRL-1 for Companies Restriction on number of layers Rules

Know the new demat rule for companies, compliance deadlines, and penalties for not issuing securities electronically.

Mandatory Demat Deadline: Convert Physical Shares to Demat by June 30 to Avoid Penalties

Emcure Pharmaceutical Limited was charged under Section 441 of the Companies Act, 2013, regarding compounding of an offence under Section 152 of the Act.

Emcure Pharmaceuticals Fined by MCA for 2015 Compliance Lapse

Judgement

This document outlines the appeal process against the ROC penalty for late filing of the Return of Allotment under Section 42(9) of the Companies Act, 2013.

Explore Our Blogs

MCA21 V3 Portal Down! Urgent System Upgrade Causes Temporary Shutdown

IL&FS Investment penalized for Delay in Submission of Consolidated Financial Results for FY 2024-25

MCA amends Form CRL-1 for Companies Restriction on number of layers Rules

Mandatory Demat Deadline: Convert Physical Shares to Demat by June 30 to Avoid Penalties

Emcure Pharmaceuticals Fined by MCA for 2015 Compliance Lapse

Company Fined for Violating Private Placement Share Issue Norms